Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04152603 · ClinicalTrials.gov registry record · NA

Better Research Interactions for Every Family

A NA study of Trust and Respect, sponsored by Seattle Children's Hospital.

Completed
Registry status
NA
Development phase
138
Enrollment target
1
Study location

NCT04152603: Completed NA study of Trust and Respect, sponsored by Seattle Children's Hospital.

NCT04152603 is a NA study of Trust and Respect that has completed, run by Seattle Children's Hospital. The registered enrollment target is 138 participants, below the 175-participant average among 6 other Trust trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04152603, a NA study of Trust and Respect, has completed, sponsored by Seattle Children's Hospital.

COMPLETED
Registry status
NA
Development phase
138 participants
Enrollment target
1
Study location

Study Summary

This is a study of the feasibility of implementing a modified recruitment approach, the Better Research Interactions for Every Family (BRIEF) Intervention, within a neonatal clinical trial. This intervention has two distinct aims: 1) improve the experience for parents asked to enroll their infant in a neonatal clinical trial; and 2) decrease disparities in enrollment within a neonatal clinical trial. The investigators will apply the BRIEF within a single site neonatal RCT, the Darbe plus IV Iron (DIVI) study, using a pre/post approach. The intervention will be implemented approximately halfway through recruitment for the DIVI study. The objectives of this study are to assess feasibility, gain preliminary experience to drive further refinement, and provide effect estimates for a future RCT of the BRIEF intervention.

Primary Outcome

The BRIEF team will compare DIVI enrollment rates for the Neonate group before vs. after implementation of the BRIEF intervention.

Interventions

  • BEHAVIORAL BRIEF Educational Module

Study Locations (1)

Washington

  • University of Washington Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 138 participants
Start Date 2022-10-10
Est. Completion 2023-12-31
Phase NA
Seattle Children's Hospital

168 total trials

What the finished NCT04152603 record still lists

NCT04152603 is an interventional study that assigns participants to a tested intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap, below the 175-participant average among 6 other Trust trials with a reported enrollment target (21% lower).

The record links to 3 conditions, with Trust appearing as the primary indexed condition, and to 1 intervention - of which BRIEF Educational Module is the first listed.

NCT04152603 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT04152603 about?

NCT04152603 is a clinical study titled "Better Research Interactions for Every Family". This is a study of the feasibility of implementing a modified recruitment approach, the Better Research Interactions for Every Family (BRIEF) Intervention, within a neonatal clinical trial. This intervention has two distinct aims: 1) improve the experience for parents asked to enroll their infant in...

What is the current status of trial NCT04152603?

This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2022-10-10. Estimated completion is 2023-12-31.

What conditions does trial NCT04152603 study?

This clinical trial studies the following conditions: Trust, Respect, Study Enrollment.

What interventions are being tested in trial NCT04152603?

The interventions under investigation include: BRIEF Educational Module (BEHAVIORAL).

Who is sponsoring clinical trial NCT04152603?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04152603 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trust

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04402788 · 138 participants · Phase 2

    Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

  • NCT04883255 · 138 participants · Early Phase 1

    Cannabis Use, Cognition, and the Endocannabinoid System in HIV

  • NCT05620784 · 138 participants · Phase 3

    Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

  • NCT05832086 · 138 participants · Phase 2

    Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04152603, the US trial registry maintained by the National Library of Medicine. NCT04152603 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.